financetom
Business
financetom
/
Business
/
Roper Technologies Q3 Adjusted Earnings, Revenue Rise; Updates 2025 EPS Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Roper Technologies Q3 Adjusted Earnings, Revenue Rise; Updates 2025 EPS Guidance
Oct 23, 2025 4:42 AM

07:22 AM EDT, 10/23/2025 (MT Newswires) -- Roper Technologies ( ROP ) reported Q3 adjusted earnings Thursday of $5.14 per diluted share, up from $4.62 a year earlier.

Analysts polled by FactSet expected $5.11.

Revenue for the quarter ended Sept. 30 was $2.02 billion, compared with $1.77 billion a year earlier.

Analysts surveyed by FactSet expected $2.03 billion.

For Q4, the company expects adjusted EPS of $5.11 to $5.16. Analysts surveyed by FactSet expect $5.23.

For 2025, Roper Technologies ( ROP ) narrowed its adjusted diluted EPS guidance to a range of $19.90 to $19.95, compared with prior outlook of $19.90 to $20.05. Analysts surveyed by FactSet expect $19.99.

The company also said its board has authorized a new share repurchase program of up to $3 billion.

Shares of the company were down 4.2% in recent Thursday premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Members Can Get WeightWatchers Prescriptions Quicker Thanks To Amazon Pharmacy Partnership
Members Can Get WeightWatchers Prescriptions Quicker Thanks To Amazon Pharmacy Partnership
Oct 20, 2025
WW International, Inc. ( WW ) , known as WeightWatchers, stock surged Monday after announcing a partnership with Amazon.com, Inc.’s  Amazon Pharmacy to make weight management medications easier to access for its clinic members. The collaboration offers real-time prescription availability, automatic savings, and home delivery options for patients using weight-loss treatments such as GLP-1 medications. The initiative comes amid soaring nationwide demand...
BRIEF-UK's CMA On Merger Update Of Global Payments / Worldpay
BRIEF-UK's CMA On Merger Update Of Global Payments / Worldpay
Oct 20, 2025
Oct 20 (Reuters) - COMPETITION AND MKTS : * COMPETITION AND MKTS - MERGER UPDATE : GLOBAL PAYMENTS ( GPN ) / WORLDPAY * UK'S CMA SAYS NOT TO REFER GLOBAL PAYMENTS / WORLDPAY MERGER TO A PHASE 2 INVESTIGATION Source text: ;)) ...
Merck Says Keytruda Shows Long-Term Survival Benefit in Non-Small Cell Lung Cancer Patients
Merck Says Keytruda Shows Long-Term Survival Benefit in Non-Small Cell Lung Cancer Patients
Oct 20, 2025
09:37 AM EDT, 10/20/2025 (MT Newswires) -- Merck ( MRK ) said Monday that new long-term data from a phase 3 trial of its cancer drug Keytruda showed sustained survival benefits in patients with earlier or advanced stages of non-small cell lung cancer. The drugmaker said that five-year follow-up data on Keytruda continued to show a clinically meaningful improvement in...
IBM Set for Another 'Solid' Quarter Driven by AI Demand, Wedbush Says
IBM Set for Another 'Solid' Quarter Driven by AI Demand, Wedbush Says
Oct 20, 2025
09:40 AM EDT, 10/20/2025 (MT Newswires) -- International Business Machines ( IBM ) is expected to record another solid quarter and top Wall Street estimates due to artificial intelligence demand for its software offerings, Wedbush analysts said in a Sunday note. The company is scheduled to report its Q3 financial results on Wednesday. Analysts polled by FactSet expect the company...
Copyright 2023-2026 - www.financetom.com All Rights Reserved